Andlauer Healthcare Group Inc.
AND.TO
TSX
| Weiss Ratings | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Reward Grade | C+ | |||
| Rating Factors | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | Weak | |||
| Growth Index | Fair | |||
| Efficiency Index | Excellent | |||
| Solvency Index | Excellent | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.41 | |||
| Price History | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -10.60% | |||
| 30-Day Total Return | -12.69% | |||
| 60-Day Total Return | -4.53% | |||
| 90-Day Total Return | -1.88% | |||
| Year to Date Total Return | -7.84% | |||
| 1-Year Total Return | -5.83% | |||
| 2-Year Total Return | -14.92% | |||
| 3-Year Total Return | -16.72% | |||
| 5-Year Total Return | 69.59% | |||
| 52-Week High % Change | -16.79% | |||
| 52-Week Low % Change | 9.63% | |||
| Price | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $48.00 | |||
| 52-Week Low Price | $36.43 | |||
| 52-Week Low Price (Date) | May 29, 2024 | |||
| 52-Week High Price (Date) | Jan 20, 2025 | |||
| Valuation | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 1.09B | |||
| Enterprise Value | 1.19B | |||
| Price/Earnings (TTM) | 34.63 | |||
| Earnings Per Share (TTM) | 1.15 | |||
| Earnings Per Share Growth | -0.19% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 3.34 | |||
| Price/Book (Q) | 5.23 | |||
| Enterprise Value/Revenue (TTM) | 2.50 | |||
| Price | $40.33 | |||
| Enterprise Value/EBITDA (TTM) | 10.86 | |||
| Enterprise Value/EBIT | 17.30 | |||
| Market Cap Category | Small Cap | |||
| Dividends and Shares | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 39.75M | |||
| Dividend Yield | 1.05% | |||
| Div. Per Share (Most Recent) | $0.11 | |||
| Dividend Per Share (TTM) | $0.42 | |||
| Payout Ratio (TTM) | 25.95% | |||
| Dividend Per Share (Most Recent) | $0.11 | |||
| Company Info | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 416 744 4900 | |||
| Address | 100 Vaughan Valley Boulevard Vaughan, ON L4H 3C5 | |||
| Website | andlauerhealthcare.com | |||
| Country | Canada | |||
| Year Founded | 1991 | |||
| Profitability | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | 14.43% | |||
| Profit Margin | 9.90% | |||
| Management Effectiveness | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | 8.56% | |||
| Return on Equity | 14.35% | |||
| Income Statement | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 474.74M | |||
| Total Revenue (TTM) | 474.74M | |||
| Revenue Per Share | $11.94 | |||
| Gross Profit (TTM) | 159.18M | |||
| EBITDA (TTM) | 109.13M | |||
| EBIT (TTM) | 68.52M | |||
| Net Income (TTM) | 47.03M | |||
| Net Income Avl. to Common (TTM) | 47.03M | |||
| Total Revenue Growth (Q YOY) | -3.26% | |||
| Earnings Growth (Q YOY) | -8.22% | |||
| EPS Diluted (TTM) | 1.15 | |||
| EPS Diluted Growth (Q YOY) | -2.47% | |||
| Balance Sheet | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 28.14M | |||
| Cash Per Share (Q) | $0.71 | |||
| Total Current Assets (Q) | 117.40M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 299.64M | |||
| Current Ratio (Q) | 1.590 | |||
| Book Value Per Share (Q) | $7.63 | |||
| Total Assets (Q) | 484.36M | |||
| Total Current Liabilities (Q) | 73.83M | |||
| Total Debt (Q) | 125.94M | |||
| Total Liabilities (Q) | 184.72M | |||
| Total Common Equity (Q) | 299.64M | |||
| Cash Flow | AND.TO - TSX | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -13.80M | |||
| Cash from Financing (TTM) | -92.29M | |||
| Net Change in Cash (TTM) | -14.07M | |||
| Levered Free Cash Flow (TTM) | 70.27M | |||
| Cash from Operations (TTM) | 90.98M | |||
